Patent directory · USPTO A61K / A61P
Patents matching “vaccine”
821 pharma patents match "vaccine" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 821 pharmaceutical patents matching "vaccine" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9274109
Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
granted -
US 9272028
Norovirus vaccine formulations
granted -
US 9259463
Chlamydia vaccine
granted -
US 9254316
Adenoviral vector-based malaria vaccines
granted -
US 9248179
Pan-lyssavirus vaccines against rabies
granted -
US 9249227
Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
granted -
US 9248172
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
granted -
US 9241981
Use of a food additive based on at least one phytonutrient for stimulating vaccine immunity against apicomplexa in animals
granted -
US 9243068
Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases
granted -
US 9241982
Purified plasmodium and vaccine compositions
granted -
US 9228002
Leishmania vaccine using sand fly salivary immunogen
granted -
US 9216213
Adjuvanted rabies vaccine with improved viscosity profile
granted -
US 9211323
Compositions and methods for administration of vaccines against dengue virus
granted -
US 9198959
Adenovirus vaccine vector and methods of use
granted -
US 9201072
Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
granted -
US 9198976
Polysaccharide-protein conjugate vaccines
granted -
US 9180179
Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
granted -
US 9181306
Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine
granted -
US 9173931
Process for preparing polysaccharide-protein conjugate vaccines
granted -
US 9173932
Vibrio cholerae O139 conjugate vaccines
granted -
US 9156891
Vaccines and methods for using the same
granted -
US 9156890
HCV vaccines and methods for using the same
granted -
US 9145548
Foot and mouth disease virus with increased stability and its use as vaccine
granted -
US 9144604
Vaccine for Shigella
granted